TCI Wealth Advisors’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
WA
RI
PA
TCI Wealth Advisors's MGNX Position: Q2 2022 in Review
TCI Wealth Advisors sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 436 shares — an estimated $4K sold.
TCI Wealth Advisors first reported a position in MGNX in Q1 2021 and held it in 4 quarters. The position peaked at $4K in Q1 2022. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.
- TCI Wealth Advisors reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
- TCI Wealth Advisors sold 436 MacroGenics shares in Q2 2022, an estimated $4K.
- TCI Wealth Advisors first reported a position in MacroGenics in Q1 2021 and held it in 4 quarters.
- TCI Wealth Advisors's MacroGenics position peaked at $4K in Q1 2022.
- 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.
Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.